cancer stanford synchrotron radiation lightsource stanford synchrotron radiation lightsource an office of science user facility home cancer releasing the brakes on apoptosis peptide antagonists trigger dimerization and autoubiquitination of cellular inhibitor of apoptosis protein 1 posted 2012 in the early stages of apoptosis a family of proteins known as caspases is typically activated caspases break down cellular components required for normal cellular function as this happens the cell shrinks and packs itself into a form that allows its removal from tissue by macrophages in cancer cells however this process is frequently defective allowing tumor growth to proceed unchecked read more allowing for apoptosis 2012 understanding why some cells don t die provides clue to treating cancer read more structural insights into the action of new anti cancer drugs structural insights into the action of new anti cancer drugs june 16 2011 3 29pm admin the photon science seminar series brings together researchers and engineers from all areas of the photon sciences to stimulate scientific exchange and make people aware of both the science that's underway using the ssrl and lcls machines and the capabilities they offer the seminars take place every wednesday at 3 00 pm in slac's building 901 redtail hawk conference room structural insights into the action of new anti cancer drugs date time june 22 2011 3 00 pm location slac redtail hawk conference room 108a speaker dong wang ucsd speaker biography dr wang's research focuses on understanding the mechanisms of cellular responses to dna damage specifically the goals of dr wang's research are 1 to understand how dna damage is recognized during transcription 2 to elucidate the structural basis of dna damage processing pathways and 3 to pave the way for rational improvement of novel anticancer drugs tags anticancer drug cancer cisplatin abstract cancer is a group of common diseases characterized by the uncontrolled growth and invasion of normal tissues over 1.5 million new cancer patients are diagnosed and 0.5 million people die of cancer each year in the united states the chemotherapy drug cisplatin represents a major landmark in the history of successful anti cancer drugs however acquired or intrinsic drug resistance to cisplatin limits its implication in chemotherapy novel anti cancer drugs are needed to overcome the drug resistance in this talk dong wang will present recent research progress toward understanding the structural basis of action of a novel anti cancer compound and knowledge that could inform future drug design 1 2 next last syndicate content the stanford synchrotron radiation lightsource is a directorate of slac national accelerator laboratory which is operated by stanford university for the department of energy other news sources slac today ssrl headlines symmetry magazine lightsources org interactions org ilc newsline spires slac national accelerator laboratory slac national accelerator laboratory menlo park ca operated by stanford university for the us department of energy office of science content owner cathy knotts privacy notice security notice and terms of use doe stanford university
